DEA schedule
Is Vemlidy a controlled substance?
Vemlidy contains tenofovir alafenamide. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Vemlidy (tenofovir alafenamide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tenofovir alafenamide is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Vemlidy?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | tenofovir alafenamide is not on the list |
Vemlidy NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 61958-2301 | VEMLIDY | tablet | 25 mg/1 | Gilead Sciences, Inc. | None |
Questions
Is Vemlidy a controlled substance?
No. Vemlidy (tenofovir alafenamide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and tenofovir alafenamide is not on the DEA controlled substances list.
Is Vemlidy a narcotic?
No. Vemlidy (tenofovir alafenamide) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Vemlidy
- What is Vemlidy used for?FDA label uses
- Generic for VemlidyFDA Orange Book
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Vemlidy Medicare Part D coverageBy plan and state
- NDC 61958-2301Vemlidy NDC record